Skip to main content
. 2008 May 3;10(2):254. doi: 10.1208/s12248-008-9033-8

Fig. 6.

Fig. 6

Anti-bacterial activities of CTZ 5–CIP 10 (containing a mixture of half of the EC50s of ceftazidime and ciprofloxacin), CTZ 10 (containing the EC50 of ceftazidime), and CIP 20 (containing the EC50 of ciprofloxacin) microparticles. Data are mean ± SD (n = 3–6). Asterisks p < 0.05 between groups